Chief Executive OfficerCoagulant TherapeuticsBerkeley, California, United States
PB1059 - Single Amino Acid Substitutions of an Antibody Specific for a Non-Active Site of Activated Protein C (APC) Yielded an Antibody Library Capable of Modulating and Uncoupling APC Pleiotropic Functions
Tuesday, June 27, 202318:30 – 19:30 ET
PB1516 - CT-001, a Novel Factor VIIa, Demonstrates Enhanced In Vitro Procoagulant Activity in Peripartum Patient Samples
